FDA Recalls Melatonin Tablets Due to Potential Labeling Errors
Aidapak Services, LLC is recalling 3 mg melatonin tablets distributed in four western states because they may be mislabeled as other supplements.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text explicitly states no illnesses or injuries have been reported, and the hazard is a labeling mixup rather than a high-risk pathogen or structural defect, fitting the 'Moderate' criteria for minor labeling errors or low-risk contamination.
Plain-English summary
Aidapak Services, LLC is voluntarily recalling 3,710 tablets of 3 mg melatonin (NDC 08770140813) due to a labeling mixup. The FDA has classified this as a Class II recall, indicating a situation where use of, or exposure to, the product may cause temporary or medically reversible adverse health consequences.
The recall is necessary because the melatonin tablets may be mislabeled as other products, including Vitamin B Complex, Multivitamin/Multimineral/Lutein, Lactase Enzyme, or Glucosamine/Chondroitin DS. The affected repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers who have purchased these specific melatonin tablets should stop using them and return them to the place of purchase or contact the recalling firm for a refund. The source text does not report any illnesses or injuries associated with this recall.
The recalled product
- Product
- MELATONIN, Tablet, 3 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 08770140813
- Manufacturer
- Aidapak Services, LLC
- Hazard
- Affected units
- 3,710
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- MELATONIN
- Tablet
- 3 mg has the following codes Pedigree: AD46257_56
- EXP: 5/15/2014
- Pedigree: W003022
- EXP: 6/12/2014
- Pedigree: W003723
- EXP: 6/26/2014
- Pedigree: AD21846_34
- EXP: 5/1/2014
- Pedigree: AD30028_28
- EXP: 5/7/2014
- Pedigree: AD60240_39
- EXP: 5/22/2014
- Pedigree: AD73521_31
- EXP: 5/30/2014
- Pedigree: W002701
- EXP: 6/5/2014
- Pedigree: W003320
- EXP: 6/19/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02